αPlGF: A New Kid on the Antiangiogenesis Block

An agent that blocks tumor angiogenesis, growth, and metastasis without affecting normal tissues—whether used alone or in combination with currently approved drugs—would change the way we treat cancer. In this issue, offer compelling evidence that a monoclonal antibody against placental growth factor (PlGF), a member of the VEGF family, has such potential in mice.